Diaceutics PLC (FRA:7DC)

Market Cap	169.83M +59.3%
Revenue (ttm)	40.13M +31.8%
Net Income	-1.77M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	210.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	275
Open	1.930
Previous Close	1.910
Day's Range	1.930 - 2.020
52-Week Range	1.240 - 2.020
Beta	n/a
RSI	79.37
Earnings Date	May 27, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using...

• Industry: Commercial Physical and Biological Research
• Founded: 2005
• Employees: 213
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7DC

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial numbers in GBP